Thornton Peter J. has filed 14 insider transactions across 1 company since August 2023.
Most recent transaction: a disposition of 11000 shares of AVADEL PHARMACEUTICALS PLC ($AVDL) on February 12, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.06% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.03% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | D | Ordinary Shares | 115060 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.11% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 95,141,000 | 9999.99% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | A | Ordinary Shares | 11000 | $0.00 | 115,055.0000 | 95,141,000 | 10.57% | 0.01% |
| Jan. 13, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | P | Ordinary Shares | 10000 | $8.05 | 104,055.0000 | 95,141,000 | 10.63% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | A | Ordinary Shares | 11000 | $0.00 | 94,055.0000 | 80,174,000 | 13.24% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 80,174,000 | 9999.99% | 0.01% |
| Aug. 1, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Thornton Peter J. | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 60,094,000 | 9999.99% | 0.05% |